Variant report

Variant	nsv428167
Chromosome Location	chr7:64980539-65208605
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1526)
CpG islands
(count:610)
Chromatin interactive
region (count:8)
LncRNA
region (count:25)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1526 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:65086672-65086673	K562	blood:	n/a	n/a
2	ARID3A	chr7:65108591-65108803	K562	blood:	n/a	n/a
3	ARID3A	chr7:65187335-65187607	HepG2	liver:	n/a	n/a
4	ATF2	chr7:65187289-65187602	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF3	chr7:65108509-65108697	K562	blood:	n/a	n/a
6	ATF3	chr7:65052369-65052549	K562	blood:	n/a	n/a
7	BATF	chr7:65137868-65138085	GM12878	blood:	n/a	chr7:65137964-65137975
8	BATF	chr7:65187278-65187582	GM12878	blood:	n/a	n/a
9	BATF	chr7:64994367-64994584	GM12878	blood:	n/a	chr7:64994452-64994463 chr7:64994511-64994522
10	BATF	chr7:65074867-65075121	GM12878	blood:	n/a	chr7:65075024-65075035
11	BATF	chr7:65060539-65060835	GM12878	blood:	n/a	n/a
12	BATF	chr7:65037824-65038043	GM12878	blood:	n/a	chr7:65037973-65037983
13	BCL11A	chr7:65060474-65060750	GM12878	blood:	n/a	n/a
14	BCL11A	chr7:65027479-65027722	GM12878	blood:	n/a	n/a
15	BCL11A	chr7:65104696-65104939	GM12878	blood:	n/a	n/a
16	BCLAF1	chr7:65187292-65187688	GM12878	blood:	n/a	n/a
17	BHLHE40	chr7:65108612-65108643	K562	blood:	n/a	n/a
18	BHLHE40	chr7:65187406-65187527	K562	blood:	n/a	n/a
19	BHLHE40	chr7:65187397-65187597	GM12878	blood:	n/a	n/a
20	BHLHE40	chr7:65196523-65196718	K562	blood:	n/a	n/a
21	BHLHE40	chr7:65164303-65164656	HepG2	liver:	n/a	n/a
22	BRCA1	chr7:65187399-65187450	GM12878	blood:	n/a	n/a
23	CBX3	chr7:65108032-65109054	K562	blood:	n/a	n/a
24	CBX3	chr7:65023139-65024334	K562	blood:	n/a	n/a
25	CBX3	chr7:65044857-65045154	K562	blood:	n/a	n/a
26	CBX3	chr7:65044881-65045212	K562	blood:	n/a	n/a
27	CBX3	chr7:65112039-65112934	K562	blood:	n/a	n/a
28	CBX3	chr7:65010320-65010760	K562	blood:	n/a	n/a
29	CBX3	chr7:65037557-65037951	K562	blood:	n/a	n/a
30	CBX3	chr7:65023365-65024326	K562	blood:	n/a	n/a
31	CBX3	chr7:65187280-65187634	K562	blood:	n/a	n/a
32	CBX3	chr7:64981959-64982333	K562	blood:	n/a	n/a
33	CBX3	chr7:65121700-65122125	K562	blood:	n/a	n/a
34	CBX3	chr7:65108350-65108892	K562	blood:	n/a	n/a
35	CBX3	chr7:65019302-65020476	K562	blood:	n/a	n/a
36	CBX3	chr7:65052214-65052650	K562	blood:	n/a	n/a
37	CCNT2	chr7:65196496-65196925	K562	blood:	n/a	chr7:65196673-65196693
38	CEBPB	chr7:65014772-65014975	HepG2	liver:	n/a	n/a
39	CEBPB	chr7:65207796-65208045	IMR90	lung:	n/a	chr7:65207922-65207933
40	CEBPB	chr7:65187391-65187532	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr7:65117938-65117955	A549	lung:	n/a	n/a
42	CEBPB	chr7:65076802-65076993	HepG2	liver:	n/a	chr7:65076927-65076938
43	CEBPB	chr7:65029790-65030215	K562	blood:	n/a	chr7:65030068-65030081 chr7:65030105-65030117
44	CEBPB	chr7:65014950-65014966	K562	blood:	n/a	n/a
45	CEBPB	chr7:65015857-65016737	K562	blood:	n/a	chr7:65016139-65016150
46	CEBPB	chr7:65116233-65116255	A549	lung:	n/a	n/a
47	CEBPB	chr7:65016010-65016210	HepG2	liver:	n/a	chr7:65016139-65016150
48	CEBPB	chr7:65096196-65096510	K562	blood:	n/a	n/a
49	CEBPB	chr7:65014950-65014977	A549	lung:	n/a	n/a
50	CEBPB	chr7:65023471-65024049	K562	blood:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:65196614-65196664	AoSMC	blood vessel:	n/a
2	chr7:65037704-65037754	ECC-1	luminal epithelium:	n/a
3	chr7:65112418-65112468	HAEpiC	amniotic membrane:	n/a
4	chr7:65112418-65112468	H1-hESC	embryonic stem cell:	embryo
5	chr7:65112418-65112468	HEK293	kidney:	embryo
6	chr7:65196614-65196664	SAEC	small airway:	n/a
7	chr7:65196614-65196664	HL-60	blood:	n/a
8	chr7:65148423-65148473	HIPEpiC	eye:	n/a
9	chr7:65037704-65037754	SAEC	small airway:	n/a
10	chr7:65112434-65112484	HIPEpiC	eye:	n/a
11	chr7:65112418-65112468	HUVEC	blood vessel:	n/a
12	chr7:65037720-65037770	IMR90	lung:	fetal
13	chr7:65112418-65112468	IMR90	lung:	fetal
14	chr7:65037704-65037754	HRCEpiC	kidney:	n/a
15	chr7:65112453-65112503	K562	blood:	n/a
16	chr7:65020034-65020084	NB4	blood:	n/a
17	chr7:65148423-65148473	Caco-2	colon:	n/a
18	chr7:65112434-65112484	HCM	heart:	n/a
19	chr7:65148423-65148473	HCPEpiC	choroid plexus:	n/a
20	chr7:65112418-65112468	RPTEC	kidney:	n/a
21	chr7:65196762-65196812	SAEC	small airway:	n/a
22	chr7:65196762-65196812	HEEpiC	esophagus:	n/a
23	chr7:65148423-65148473	GM12891	blood:	n/a
24	chr7:65196762-65196812	CMK	blood:	n/a
25	chr7:65020034-65020084	SK-N-SH_RA	brain:	n/a
26	chr7:65196614-65196664	BE2_C	brain:	n/a
27	chr7:65112434-65112484	HepG2	liver:	n/a
28	chr7:65112453-65112503	AG10803	skin:	n/a
29	chr7:65020034-65020084	AoSMC	blood vessel:	n/a
30	chr7:65196762-65196812	HIPEpiC	eye:	n/a
31	chr7:65112418-65112468	HPAEpiC	pulmonary alveolar:	n/a
32	chr7:65196881-65196931	HIPEpiC	eye:	n/a
33	chr7:65196762-65196812	NT2-D1	testis:	n/a
34	chr7:65020034-65020084	Hepatocyte	liver:	n/a
35	chr7:65196881-65196931	ECC-1	luminal epithelium:	n/a
36	chr7:65196881-65196931	PANC-1	pancreas:	n/a
37	chr7:65037704-65037754	ProgFib	skin:	n/a
38	chr7:65196614-65196664	Jurkat	blood:	n/a
39	chr7:65196881-65196931	H1-hESC	embryonic stem cell:	embryo
40	chr7:65196762-65196812	AG04449	skin:	fetal
41	chr7:65112434-65112484	HRCEpiC	kidney:	n/a
42	chr7:65148423-65148473	MCF-7	breast:	n/a
43	chr7:65020034-65020084	SAEC	small airway:	n/a
44	chr7:65196881-65196931	K562	blood:	n/a
45	chr7:65037704-65037754	AG09309	skin:	n/a
46	chr7:65196762-65196812	MCF-7	breast:	n/a
47	chr7:65196881-65196931	HMEC	breast:	n/a
48	chr7:65196881-65196931	HEK293	kidney:	embryo
49	chr7:65112434-65112484	HMEC	breast:	n/a
50	chr7:65020034-65020084	IMR90	lung:	fetal

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:65196532..65198137-chr7:65200212..65201729,2	K562	blood:
2	chr7:65189487..65191931-chr7:65193977..65196871,2	K562	blood:
3	chr7:65189487..65191931-chr7:65193977..65196871,2	K562	blood:
4	chr7:56101662..56102254-chr7:65196450..65196951,2	NB4	blood:
5	chr7:65207293..65209000-chr7:65214338..65216857,2	MCF-7	breast:
6	chr7:65204274..65205998-chr7:65215149..65217167,2	MCF-7	breast:
7	chr7:65196532..65198137-chr7:65200212..65201729,2	K562	blood:
8	chr7:65200758..65202338-chr7:65214694..65217297,2	MCF-7	breast:

(count:25 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GUSB-5	chr7:65191744-65192124	NONHSAT121100
2	lnc-GUSB-5	chr7:65192028-65192081	NONHSAT121101
3	lnc-GUSB-5	chr7:65187627-65189100	ENSG00000248460
4	lnc-GUSB-5	chr7:65205857-65206107	NONHSAT121098
5	lnc-GUSB-5	chr7:65191744-65191917	NONHSAT121101
6	lnc-GUSB-5	chr7:65191744-65191917	ENSG00000248460
7	lnc-GUSB-5	chr7:65205858-65206107	ENSG00000248460
8	lnc-GUSB-5	chr7:65187105-65187263	NONHSAT121098
9	lnc-GUSB-5	chr7:65180472-65180823	NONHSAT121099
10	lnc-GUSB-5	chr7:65172701-65172795	NONHSAT121098
11	lnc-GUSB-5	chr7:65192028-65192081	ENSG00000248460
12	lnc-GUSB-5	chr7:65187005-65187097	NONHSAT121100
13	lnc-GUSB-5	chr7:65191744-65191917	NONHSAT121099
14	lnc-GUSB-5	chr7:65190450-65191179	NONHSAT121098
15	lnc-GUSB-5	chr7:65196535-65198801	NONHSAT121102
16	lnc-GUSB-5	chr7:65199235-65199344	NONHSAT121098
17	lnc-GUSB-9	chr7:65168869-65170261	NONHSAT121096
18	lnc-GUSB-5	chr7:65180784-65180823	NONHSAT121098
19	lnc-GUSB-5	chr7:65192000-65192081	NONHSAT121102
20	lnc-GUSB-5	chr7:65205858-65206107	NONHSAT121101
21	lnc-GUSB-5	chr7:65196535-65197024	NONHSAT121098
22	lnc-GUSB-5	chr7:65192028-65192081	NONHSAT121098
23	lnc-GUSB-5	chr7:65187621-65189100	NONHSAT121101
24	lnc-GUSB-5	chr7:65203730-65203960	NONHSAT121098
25	lnc-GUSB-5	chr7:65192028-65192081	NONHSAT121099

No data

Variant related genes	Relation type
ENSG00000230386	TF binding region
ENSG00000235421	TF binding region
ENSG00000269558	TF binding region
INTS4L2	TF binding region
ENSG00000230386	CpG island
ENSG00000235421	CpG island
ENSG00000269558	CpG island
INTS4L2	CpG island
ENSG00000228409	chromatin interactions
ENSG00000146733	chromatin interactions
LIN54	miRNA target sites
MCOLN2	miRNA target sites
MFHAS1	miRNA target sites

Extended variants
information (count: 1978 )
Associated
traits (count: 78 )

Variant overlapped rSNPs/rCNVs (count:1978 , 50 per page) page: 1 2 3 4 5 6 7 ... 40

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs377593307	chr7:65019922-65019923	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs573424542	chr7:65019948-65019949	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs545406980	chr7:65019950-65019951	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs112577154	chr7:65020018-65020019	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs62471476	chr7:65020038-65020039	Inactive region	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs62471479	chr7:65024422-65024423	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs558656577	chr7:65024517-65024518	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs28703897	chr7:65037481-65037482	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs370191561	chr7:65037492-65037493	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs372544459	chr7:65037504-65037505	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs7457767	chr7:65037548-65037549	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
12	rs2949503	chr7:65037566-65037567	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs369917451	chr7:65037569-65037570	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs547187472	chr7:65037578-65037579	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs7457785	chr7:65037580-65037581	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs567180525	chr7:65037582-65037583	Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs538947108	chr7:65037624-65037625	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs185143442	chr7:65037642-65037643	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs73700023	chr7:65037645-65037646	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs373525935	chr7:65037654-65037655	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs377564408	chr7:65037655-65037656	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs148957850	chr7:65037658-65037659	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs558949535	chr7:65037659-65037660	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs564480003	chr7:65037664-65037665	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs6150140	chr7:65037666-65037667	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs575553687	chr7:65037667-65037668	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs112267439	chr7:65037669-65037670	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs554660201	chr7:65037670-65037671	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs574567016	chr7:65037673-65037674	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs542444670	chr7:65037682-65037683	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs4997955	chr7:65037683-65037684	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	mRNA abundance
32	rs62471484	chr7:65037688-65037689	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs374263911	chr7:65037690-65037691	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs112044001	chr7:65037692-65037693	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs375844053	chr7:65037698-65037699	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs376902109	chr7:65037710-65037711	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs565137922	chr7:65037721-65037722	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs530430818	chr7:65037742-65037743	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs1814842	chr7:65037743-65037744	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs1574984	chr7:65037774-65037775	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs62471485	chr7:65037776-65037777	Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs201343720	chr7:65055812-65055813	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs199800307	chr7:65055821-65055822	Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs183272482	chr7:65055828-65055829	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs62472288	chr7:65055831-65055832	Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
46	rs369158936	chr7:65055848-65055849	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs201419243	chr7:65055862-65055863	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs199610975	chr7:65055886-65055887	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs574126889	chr7:65055898-65055899	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs200495890	chr7:65055916-65055917	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:78)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Follicular lymphoma	20505157	CNVD
Biliary cancer	19435499	CNVD
Williams-beuren syndrome	22470819	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21750150	CNVD
Cancer	21183584	CNVD
Hepatocellular carcinoma	16750200	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Glioblastoma	21080181	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Astrocytoma	22246337	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Acute monocytic leukemia	16498392	CNVD
Prostate cancer	16461572	CNVD
Salivary gland tumor	18059337	CNVD
Multiple myeloma	17550852	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:630 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:65037400-65037600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr7:65037400-65037600	Active TSS	Psoas Muscle	Psoas
3	chr7:65037400-65037800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr7:65037400-65037800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
5	chr7:65037400-65037800	Enhancers	Primary B cells from peripheral blood	blood
6	chr7:65037400-65037800	Enhancers	Primary T cells fromperipheralblood	blood
7	chr7:65037400-65037800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
8	chr7:65037400-65037800	Active TSS	Right Atrium	heart
9	chr7:65037600-65037800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr7:65037600-65037800	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
11	chr7:65037600-65037800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
12	chr7:65037600-65037800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
13	chr7:65037600-65037800	Enhancers	Duodenum Smooth Muscle	Duodenum
14	chr7:65037600-65037800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
15	chr7:65037600-65037800	Bivalent Enhancer	Fetal Thymus	thymus
16	chr7:65037600-65037800	Flanking Bivalent TSS/Enh	Psoas Muscle	Psoas
17	chr7:65037600-65037800	Enhancers	Stomach Smooth Muscle	stomach
18	chr7:65055800-65056000	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr7:65058600-65059000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr7:65059000-65059200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr7:65074200-65075200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
22	chr7:65078400-65078600	Enhancers	iPS-20b Cell Line	embryonic stem cell
23	chr7:65078400-65078800	Enhancers	iPS-15b Cell Line	embryonic stem cell
24	chr7:65082000-65082200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr7:65082200-65088800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr7:65086400-65087000	Enhancers	Primary B cells from peripheral blood	blood
27	chr7:65088400-65090400	Enhancers	iPS-15b Cell Line	embryonic stem cell
28	chr7:65088800-65090600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr7:65089400-65089600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr7:65089400-65089600	Enhancers	iPS-20b Cell Line	embryonic stem cell
31	chr7:65089400-65090000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr7:65089400-65090000	Enhancers	Adipose Nuclei	Adipose
33	chr7:65089400-65090400	Enhancers	HUES64 Cell Line	embryonic stem cell
34	chr7:65089400-65090600	Enhancers	iPS-18 Cell Line	embryonic stem cell
35	chr7:65089600-65090200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
36	chr7:65089600-65090600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr7:65089600-65090600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
38	chr7:65090200-65090800	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr7:65090600-65090800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr7:65090800-65091600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr7:65091600-65091800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr7:65112200-65112400	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr7:65112200-65112600	Active TSS	H1 Cell Line	embryonic stem cell
44	chr7:65112200-65112600	Active TSS	HUES64 Cell Line	embryonic stem cell
45	chr7:65112200-65112600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr7:65112200-65112600	Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
47	chr7:65112200-65112800	Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
48	chr7:65112200-65112800	Active TSS	Psoas Muscle	Psoas
49	chr7:65112200-65112800	Active TSS	Right Ventricle	heart
50	chr7:65112400-65112600	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links